Autologous Bone Marrow Cell Transplantation Increases Leg Perfusion and Reduces Amputations in Patients with Advanced Critical Limb Ischemia Due to Peripheral Artery Disease
- 1 March 2009
- journal article
- clinical trial
- Published by SAGE Publications in Cell Transplantation
- Vol. 18 (3) , 371-380
- https://doi.org/10.3727/096368909788534942
Abstract
Bone marrow cell transplantation has been shown to induce angiogenesis and thus improve ischemic artery disease. This study evaluates the effects of intramuscular bone marrow cell transplantation in patients with limb-threatening critical limb ischemia with a very high risk for major amputation. After failed or impossible operative and/or interventional revascularization and after unsuccessful maximum conservative therapy, 51 patients with impending major amputation due to severe critical limb ischemia had autologous bone marrow cells (BMC) transplanted into the ischemic leg. Patients 1–12 received Ficoll-isolated bone marrow mononuclear cells (total cell number 1.1 ± 1.1 × 109), patients 13–51 received point of care isolated bone marrow total nucleated cells (3.0 ± 1.7 × 109). Limb salvage was 59% at 6 months and 53% at last follow-up (mean 411 ± 261 days, range 175–1186). Perfusion measured with ankle-brachial index (ABI) and transcutaneous oxygen tension (tcpO2) at baseline and after 6 months increased in patients with consecutive limb salvage (ABI 0.33 ± 0.18 to 0.46 ± 0.15, tcpO2 12 ± 12 to 25 ± 15 mmHg) and did not change in patients eventually undergoing major amputation. No difference in clinical outcome between the isolation methods were seen. Clinically most important, patients with limb salvage improved from a mean Rutherford category of 4.9 at baseline to 3.3 at 6 months ( p = 0.0001). Analgesics consumption was reduced by 62%. Total walking distance improved in nonamputees from zero to 40 m. Three severe periprocedural adverse events resolved without sequelae, and no unexpected long-term adverse events occurred. In no-option patients with end-stage critical limb ischemia due to peripheral artery disease, bone marrow cell transplantation is a safe procedure that can improve leg perfusion sufficiently to reduce major amputations and permit durable limb salvage.Keywords
This publication has 35 references indexed in Scilit:
- Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxiaProceedings of the National Academy of Sciences, 2007
- ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)Circulation, 2006
- Risk Factors for Poor Collateral Development in ClaudicationVascular and Endovascular Surgery, 2005
- Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trialJournal of Vascular Surgery, 2005
- Homing to Hypoxia: HIF-1 as a Mediator of Progenitor Cell Recruitment to Injured TissueTrends in Cardiovascular Medicine, 2005
- Collateral Growth in the Peripheral Circulation: A ReviewVascular and Endovascular Surgery, 2004
- Megakaryocyte–Bone Marrow Stromal Cell Aggregates Demonstrate Increased Colony Formation and Alkaline Phosphatase Expressionin VitroTissue Engineering, 2004
- Arteriogenesis The Development and Growth of Collateral ArteriesMicrocirculation, 2003
- A 2: Epidemiology, natural history, risk factorsJournal of Vascular Surgery, 2000
- Incidence, Natural History and Cardiovascular Events in Symptomatic and Asymptomatic Peripheral Arterial Disease in the General PopulationInternational Journal of Epidemiology, 1996